Finance

Lists
Why is OSE down 2,12%?
Dive Deeper
OSE:EPA
Ose Immunotherapeutics SA
1,71 €
-2,12%
(-0,037) 1D
6 қар., 17:35:26 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OSE...
Open
1,72 €
High
1,74 €
Low
1,67 €
Mkt. cap
39,53 млн
Avg. vol.
177,78 м.
Volume
98,86 мың
52-wk high
5,92 €
52-wk low
1,67 €
EPS
-1,69 €
Shares outstanding
23,56 млн
No. of employees
64
Open
1,72 €
High
1,74 €
Low
1,67 €
Mkt. cap
39,53 млн
Avg. vol.
177,78 м.
Volume
98,86 мың
52-wk high
5,92 €
52-wk low
1,67 €
EPS
-1,69 €
Shares outstanding
23,56 млн
No. of employees
64
News stories
From web sources and news partners
About Ose Immunotherapeutics SA
CEO-
Employees64
Founded2004 ж. 17 қар.
Headquarters-
SectorHealth Care
Industry-
Websiteose-immuno.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2024 ж. қыр.
2024 ж. жел.
Revenue
431,00 м.
431,00 м.
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
8,28 млн
8,28 млн
Total research and development expenses
-
-
Selling, general, and admin expenses
1,08 млн
1,08 млн
Operating expense
10,22 млн
10,22 млн
Total operating expenses
10,22 млн
10,22 млн
Operating income
-9,79 млн
-9,79 млн
Other non operating income
-611,00 м.
-611,00 м.
EBT including unusual items
-10,44 млн
-10,44 млн
EBT excluding unusual items
-10,53 млн
-10,53 млн
Income tax expense
-576,50 м.
-576,50 м.
Effective tax rate
5,52%
5,52%
Other operating expenses
41,00 мың
41,00 мың
Net income
-9,86 млн
-9,86 млн
Net profit margin
-2 288,86%
-2 288,86%
Earnings per share
-
-
Interest and investment income
571,00 м.
571,00 м.
Interest expense
-707,50 м.
-707,50 м.
Net interest expenses
-136,50 м.
-136,50 м.
Depreciation and amortization charges
-
-
EBITDA
-9,74 млн
-9,74 млн
Gain or loss from assets sale
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары